|
1
|
Karsenty G and Wagner EF: Reaching a
genetic and molecular understanding of skeletal development. Dev
Cell. 2:389–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boyce BF and Xing L: Functions of
RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem
Biophys. 473:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hauschka PV, Lian JB, Cole DE and Gundberg
CM: Osteocalcin and matrix Gla protein: Vitamin K-dependent
proteins in bone. Physiol Rev. 69:990–1047. 1989.PubMed/NCBI
|
|
4
|
Ducy P, Desbois C, Boyce B, Pinero G,
Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, et
al: Increased bone formation in osteocalcin-deficient mice. Nature.
382:448–452. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karsenty G and Ferron M: The contribution
of bone to whole-organism physiology. Nature. 481:314–320. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gogakos AI, Bassett JH Duncan and Williams
GR: Thyroid and bone. Arch Biochem Biophys. 503:129–136. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vestergaard P and Mosekilde L:
Hyperthyroidism, bone mineral, and fracture risk - a meta-analysis.
Thyroid. 13:585–593. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheng SY, Leonard JL and Davis PJ:
Molecular aspects of thyroid hormone actions. Endocr Rev.
31:139–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mullur R, Liu YY and Brent GA: Thyroid
hormone regulation of metabolism. Physiol Rev. 94:355–382. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kasono K, Sato K, Han DC, Fujii Y,
Tsushima T and Shizume K: Stimulation of alkaline phosphatase
activity by thyroid hormone in mouse osteoblast-like cells
(MC3T3-E1): A possible mechanism of hyperalkaline phosphatasia in
hyperthyroidism. Bone Miner. 4:355–363. 1988.PubMed/NCBI
|
|
11
|
Ishisaki A, Tokuda H, Yoshida M, Hirade K,
Kunieda K, Hatakeyama D, Shibata T and Kozawa O: Activation of p38
mitogen-activated protein kinase mediates thyroid hormone-
stimulated osteocalcin synthesis in osteoblasts. Mol Cell
Endocrinol. 214:189–195. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kanno Y, Ishisaki A, Yoshida M, Nakajima
K, Tokuda H, Numata O and Kozawa O: Adenylyl cyclase-cAMP system
inhibits thyroid hormone-stimulated osteocalcin synthesis in
osteoblasts. Mol Cell Endocrinol. 229:75–82. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Baggio LL and Drucker DJ: Biology of
incretins: GLP-1 and GIP. Gastroenterology. 132:2131–2157. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Holst JJ: The physiology of glucagon-like
peptide 1. Physiol Rev. 87:1409–1439. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bollag RJ, Zhong Q, Phillips P, Min L,
Zhong L, Cameron R, Mulloy AL, Rasmussen H, Qin F, Ding KH, et al:
Osteoblast- derived cells express functional glucose-dependent
insulinotropic peptide receptors. Endocrinology. 141:1228–1235.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bollag RJ, Zhong Q, Ding KH, Phillips P,
Zhong L, Qin F, Cranford J, Mulloy AL, Cameron R and Isales CM:
Glucose-dependent insulinotropic peptide is an integrative hormone
with osteotropic effects. Mol Cell Endocrinol. 177:35–41. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sanz C, Vázquez P, Blázquez C, Barrio PA,
Alvarez MM and Blázquez E: Signaling and biological effects of
glucagon-like peptide 1 on the differentiation of mesenchymal stem
cells from human bone marrow. Am J Physiol Endocrinol Metab.
298:E634–E643. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kozawa O, Tokuda H, Miwa M, Kotoyori J and
Oiso Y: Cross-talk regulation between cyclic AMP production and
phosphoinositide hydrolysis induced by prostaglandin E2 in
osteoblast-like cells. Exp Cell Res. 198:130–134. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang W, Yang N and Shi XM: Regulation of
mesenchymal stem cell osteogenic differentiation by
glucocorticoid-induced leucine zipper (GILZ). J Biol Chem.
283:4723–4729. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Simpson DA, Feeney S, Boyle C and Stitt
AW: Retinal VEGF mRNA measured by SYBR green I fluorescence: A
versatile approach to quantitative PCR. Mol Vis. 6:178–183.
2000.PubMed/NCBI
|
|
22
|
Seino Y and Yabe D: Glucose-dependent
insulinotropic polypeptide and glucagon-like peptide-1: Incretin
actions beyond the pancreas. J Diabetes Investig. 4:108–130. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Godinho RO, Duarte T and Pacini ES: New
perspectives in signaling mediated by receptors coupled to
stimulatory G protein: The emerging significance of cAMP effux and
extracellular cAMP-adenosine pathway. Front Pharmacol. 6:582015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lecka-Czernik B: Safety of anti-diabetic
therapies on bone. Clin Rev Bone Miner Metab. 11:49–58. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee NK and Karsenty G: Reciprocal
regulation of bone and energy metabolism. Trends Endocrinol Metab.
19:161–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
